FIVE Crosses Above Average Analyst Target
US MARKET | Wed, 26 Nov 2025, 7:01AM ET
In recent trading, shares of Five Below Inc (Symbol: FIVE) have crossed above the average analyst 12-month target price of $158.10, changing hands for $163.18/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on val
Continue reading at Nasdaq
36m
Yeti Holdings Reaches Analyst Target Price
US MARKET | Wed, 26 Nov 2025, 7:01AM ET
In recent trading, shares of Yeti Holdings Inc (Symbol: YETI) have crossed above the average analyst 12-month target price of $40.86, changing hands for $41.23/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on va
Continue reading at Nasdaq
36m
Greenbrier Companies Reaches Analyst Target Price
US MARKET | Wed, 26 Nov 2025, 7:01AM ET
In recent trading, shares of Greenbrier Companies Inc (Symbol: GBX) have crossed above the average analyst 12-month target price of $43.67, changing hands for $44.33/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrad
Continue reading at Nasdaq
36m
Merck Reaches Analyst Target Price
US MARKET | Wed, 26 Nov 2025, 7:01AM ET
In recent trading, shares of Merck & Co Inc (Symbol: MRK) have crossed above the average analyst 12-month target price of $103.30, changing hands for $105.66/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on
Continue reading at Nasdaq
36m
FTI Crosses Above Average Analyst Target
US MARKET | Wed, 26 Nov 2025, 7:01AM ET
In recent trading, shares of TechnipFMC plc (Symbol: FTI) have crossed above the average analyst 12-month target price of $44.58, changing hands for $45.03/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuat
Continue reading at Nasdaq
36m
Haemonetics Reaches Analyst Target Price
US MARKET | Wed, 26 Nov 2025, 7:01AM ET
In recent trading, shares of Haemonetics Corp. (Symbol: HAE) have crossed above the average analyst 12-month target price of $80.40, changing hands for $80.63/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on val
Continue reading at Nasdaq
36m
LEN Crosses Above Average Analyst Target
US MARKET | Wed, 26 Nov 2025, 7:01AM ET
In recent trading, shares of Lennar Corp (Symbol: LEN) have crossed above the average analyst 12-month target price of $127.57, changing hands for $131.08/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuati
Continue reading at Nasdaq
36m
AMTM Crosses Above Average Analyst Target
US MARKET | Wed, 26 Nov 2025, 7:01AM ET
In recent trading, shares of Amentum Holdings Inc (Symbol: AMTM) have crossed above the average analyst 12-month target price of $28.18, changing hands for $30.00/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on
Continue reading at Nasdaq
37m
Medical Properties Trust Reaches Analyst Target Price
US MARKET | Wed, 26 Nov 2025, 7:01AM ET
In recent trading, shares of Medical Properties Trust Inc (Symbol: MPW) have crossed above the average analyst 12-month target price of $5.50, changing hands for $5.65/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgra
Continue reading at Nasdaq
37m
BKU Crosses Above Average Analyst Target
US MARKET | Wed, 26 Nov 2025, 7:01AM ET
In recent trading, shares of BankUnited Inc. (Symbol: BKU) have crossed above the average analyst 12-month target price of $42.11, changing hands for $43.33/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valua
Continue reading at Nasdaq
37m
Viking Holdings Reaches Analyst Target Price
US MARKET | Wed, 26 Nov 2025, 6:59AM ET
In recent trading, shares of Viking Holdings Ltd (Symbol: VIK) have crossed above the average analyst 12-month target price of $64.31, changing hands for $67.87/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on v
Continue reading at Nasdaq
39m
TMDX Crosses Above Average Analyst Target
US MARKET | Wed, 26 Nov 2025, 6:59AM ET
In recent trading, shares of TransMedics Group Inc (Symbol: TMDX) have crossed above the average analyst 12-month target price of $141.64, changing hands for $146.00/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade
Continue reading at Nasdaq
39m
AMAT Crosses Above Average Analyst Target
US MARKET | Wed, 26 Nov 2025, 6:59AM ET
In recent trading, shares of Applied Materials, Inc. (Symbol: AMAT) have crossed above the average analyst 12-month target price of $238.68, changing hands for $242.46/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgra
Continue reading at Nasdaq
39m
S & T Bancorp Reaches Analyst Target Price
US MARKET | Wed, 26 Nov 2025, 6:57AM ET
In recent trading, shares of S & T Bancorp Inc (Symbol: STBA) have crossed above the average analyst 12-month target price of $40.40, changing hands for $40.63/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade
Continue reading at Nasdaq
40m
Solventum Reaches Analyst Target Price
US MARKET | Wed, 26 Nov 2025, 6:57AM ET
In recent trading, shares of Solventum Corp (Symbol: SOLV) have crossed above the average analyst 12-month target price of $84.70, changing hands for $85.77/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valua
Continue reading at Nasdaq
40m
Protagonist Therapeutics Reaches Analyst Target Price
US MARKET | Wed, 26 Nov 2025, 6:57AM ET
In recent trading, shares of Protagonist Therapeutics Inc (Symbol: PTGX) have crossed above the average analyst 12-month target price of $89.77, changing hands for $89.86/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: down
Continue reading at Nasdaq
40m
Atkore Reaches Analyst Target Price
US MARKET | Wed, 26 Nov 2025, 6:56AM ET
In recent trading, shares of Atkore Inc (Symbol: ATKR) have crossed above the average analyst 12-month target price of $63.00, changing hands for $65.10/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation
Continue reading at Nasdaq
41m
more